Drug Shortage Report for MINT-PERINDOPRIL
Report ID | 95941 |
Drug Identification Number | 02476789 |
Brand name | MINT-PERINDOPRIL |
Common or Proper name | Perindopril |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | PERINDOPRIL ERBUMINE |
Strength(s) | 8MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-09 |
Estimated end date | |
Actual end date | 2019-10-21 |
Shortage status | Resolved |
Updated date | 2019-10-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-10-09 | English | Compare |
v2 | 2019-10-09 | French | Compare |
v3 | 2019-10-10 | English | Compare |
v4 | 2019-10-21 | English | Compare |
v5 | 2019-10-21 | French | Compare |
v6 | 2019-10-22 | English | Compare |
Showing 1 to 6 of 6